Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Randomized, Investigator-Blind Study to Compare Three Days of Treatment With Paracetamol (500 mg) / Dimethindene Maleate (1 mg) / Phenylephrine Hydrochloride (10 mg) Tablets Versus Paracetamol 500 mg Alone in the Treatment of Nasal Congestion and Other Symptoms Due to Cold and Flu

NCT01448057 is registered in ClinicalTrials.gov with Novartis as lead sponsor.

NCT NCT01448057
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01448057 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Randomized, Investigator-Blind Study to Compare Three Days of Treatment With Paracetamol (500 mg) / Dimethindene Maleate (1 mg) / Phenylephrine Hydrochloride (10 mg) Tablets Versus Paracetamol 500 mg Alone in the Treatment of Nasal Congestion and Other Symptoms Due to Cold and Flu
Lead sponsor
Novartis
Phase
Phase 3
Overall status
Completed
Start date
July 31, 2013
Completion date
August 31, 2015
Enrollment
341 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

nasal congestion, rhinorrhea, sneezing, upper respiratory tract infection